Robert J Shprintzen1, Anne Marie Higgins, Kevin Antshel, Wanda Fremont, Nancy Roizen, Wendy Kates. 1. Center for the Diagnosis, Treatment and Study of Velo-Cardio-Facial Syndrome, Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University, Syracuse, New York 13210, USA. shprintr@upstate.edu
Abstract
PURPOSE OF REVIEW: Velo-cardio-facial syndrome has emerged from obscurity to become one of the most researched disorders this past decade. It is one of the most common genetic syndromes in humans, the most common contiguous gene syndrome in humans, the most common syndrome of cleft palate, and the most common syndrome of conotruncal heart malformations. Velo-cardio-facial syndrome has an expansive phenotype, a factor reflected in the wide range of studies that cover both clinical features and molecular genetics. In this review, we cover multiple areas of research during the past year, including psychiatric disorders, neuroimaging, and the delineation of clinical features. RECENT FINDINGS: The identification of candidate genes for heart anomalies, mental illness, and other clinical phenotypes has been reported in the past year with a focus on TBX1 for cardiac and craniofacial phenotypes and COMT and PRODH for psychiatric disorders. The expansive phenotype of velo-cardio-facial syndrome continues to grow with new behavioral and structural anomalies reported. Treatment issues are beginning to draw attention, although most authors continue to focus on diagnostic issues. SUMMARY: Its high population prevalence, estimated to be as common as 1:2000 has sparked a large amount of research, as has the model the syndrome serves for identifying the causes of mental illness and learning disabilities, but it is obvious that more information is needed. Intensive scrutiny of velo-cardio-facial syndrome will undoubtedly continue for many years to come with the hope that researchers will turn more of their attention to treatment and treatment outcomes.
PURPOSE OF REVIEW: Velo-cardio-facial syndrome has emerged from obscurity to become one of the most researched disorders this past decade. It is one of the most common genetic syndromes in humans, the most common contiguous gene syndrome in humans, the most common syndrome of cleft palate, and the most common syndrome of conotruncal heart malformations. Velo-cardio-facial syndrome has an expansive phenotype, a factor reflected in the wide range of studies that cover both clinical features and molecular genetics. In this review, we cover multiple areas of research during the past year, including psychiatric disorders, neuroimaging, and the delineation of clinical features. RECENT FINDINGS: The identification of candidate genes for heart anomalies, mental illness, and other clinical phenotypes has been reported in the past year with a focus on TBX1 for cardiac and craniofacial phenotypes and COMT and PRODH for psychiatric disorders. The expansive phenotype of velo-cardio-facial syndrome continues to grow with new behavioral and structural anomalies reported. Treatment issues are beginning to draw attention, although most authors continue to focus on diagnostic issues. SUMMARY: Its high population prevalence, estimated to be as common as 1:2000 has sparked a large amount of research, as has the model the syndrome serves for identifying the causes of mental illness and learning disabilities, but it is obvious that more information is needed. Intensive scrutiny of velo-cardio-facial syndrome will undoubtedly continue for many years to come with the hope that researchers will turn more of their attention to treatment and treatment outcomes.
Authors: Nancy J Roizen; Anne M Higgins; Kevin M Antshel; Wanda Fremont; Robert Shprintzen; Wendy R Kates Journal: J Pediatr Date: 2010-06-19 Impact factor: 4.406
Authors: Maria Delio; Tingwei Guo; Donna M McDonald-McGinn; Elaine Zackai; Sean Herman; Mark Kaminetzky; Anne Marie Higgins; Karlene Coleman; Carolyn Chow; Maria Jalbrzikowski; Maria Jarlbrzkowski; Carrie E Bearden; Alice Bailey; Anders Vangkilde; Line Olsen; Charlotte Olesen; Flemming Skovby; Thomas M Werge; Ludivine Templin; Tiffany Busa; Nicole Philip; Ann Swillen; Joris R Vermeesch; Koen Devriendt; Maude Schneider; Sophie Dahoun; Stephan Eliez; Kelly Schoch; Stephen R Hooper; Vandana Shashi; Joy Samanich; Robert Marion; Therese van Amelsvoort; Erik Boot; Petra Klaassen; Sasja N Duijff; Jacob Vorstman; Tracy Yuen; Candice Silversides; Eva Chow; Anne Bassett; Amos Frisch; Abraham Weizman; Doron Gothelf; Maria Niarchou; Marianne van den Bree; Michael J Owen; Damian Heine Suñer; Jordi Rosell Andreo; Marco Armando; Stefano Vicari; Maria Cristina Digilio; Adam Auton; Wendy R Kates; Tao Wang; Robert J Shprintzen; Beverly S Emanuel; Bernice E Morrow Journal: Am J Hum Genet Date: 2013-02-28 Impact factor: 11.025
Authors: Fabíola P Monteiro; Társis P Vieira; Ilária C Sgardioli; Miriam C Molck; Ana Paula Damiano; Josiane Souza; Isabella L Monlleó; Marshall I B Fontes; Agnes C Fett-Conte; Têmis M Félix; Gabriela F Leal; Erlane M Ribeiro; Claudio E M Banzato; Clarissa de R Dantas; Iscia Lopes-Cendes; Vera Lúcia Gil-da-Silva-Lopes Journal: Eur J Pediatr Date: 2013-02-26 Impact factor: 3.183
Authors: Kevin M Antshel; Kaitlin Hendricks; Robert Shprintzen; Wanda Fremont; Anne Marie Higgins; Stephen V Faraone; Wendy R Kates Journal: J Pediatr Date: 2013-01-18 Impact factor: 4.406